| Financial Year |
March 31 2023 |
| Monetary Funds |
57,128,349.62 |
| Held-for-trading Financial Assets |
1,798,825.24 |
| Notes Receivable |
21,718,524.75 |
| Accounts Receivable |
131,716,174.24 |
| Advances to Suppliers |
3,843,170.86 |
| Other Receivables |
2,487,390.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
116,895,581.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,631,125.94 |
| Other Current Assets |
8,193,718.33 |
| Total Current Assets |
447,512,204.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
46,061,486.92 |
| Long-term Equity Investment |
50,149,623.49 |
| Investment Properties |
-- |
| Fixed Assetes |
123,391,814.10 |
| Under-construction Projects |
15,203,700.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,943,797.69 |
| R&D expenses |
-- |
| Goodwill |
51,553,460.26 |
| Long-Term Deferred and Prepaid Expenses |
14,888,242.62 |
| Deferred Income Tax Assets |
17,539,215.48 |
| Other Non-Current Assets |
19,138,902.70 |
| Sub-Total of Non-Current Assets |
476,756,265.40 |
| Total Assets |
924,268,470.00 |
| Short-Term Loans |
20,022,346.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
34,077,438.65 |
| Accounts Payable |
100,415,055.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,693,583.48 |
| Taxes Payable |
3,594,519.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,791,498.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
303,973.27 |
| Other Current Liabilities |
2,834,294.16 |
| Sub-Total of Current Liabilities |
178,993,177.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,865,918.02 |
| Deferred Income Tax Liabilities |
5,573,772.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,819,040.06 |
| Total Liabilities |
192,812,218.00 |
| Paid-In Capital(Or Share Stock) |
171,111,111.00 |
| Capital Surplus |
257,042,275.61 |
| Surplus Reserve |
29,667,267.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
261,317,701.97 |
| Minority Stockholder's Interest |
11,397,908.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
720,058,343.50 |
| Owner's Equity（Stockholder's Equity） |
731,456,252.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
924,268,470.00 |
